Cargando…

Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer’s disease: a prospective, observational study of factors affecting survival time from admission to death

BACKGROUND: The survival time in nursing homes (NHs) in Alzheimer’s disease (AD) might be affected by sociodemographic/clinical characteristics, rate of disease progression, and use of specific medications and community-based services. Whether different aspects of cholinesterase inhibitor (ChEI) the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wattmo, Carina, Londos, Elisabet, Minthon, Lennart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007849/ https://www.ncbi.nlm.nih.gov/pubmed/27581368 http://dx.doi.org/10.1186/s12883-016-0675-3

Ejemplares similares

Short-Term Response to Cholinesterase Inhibitors in Alzheimer’s Disease Delays Time to Nursing Home Placement
por: Wattmo, Carina, et al.
Publicado: (2018)

Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2014)

A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy
por: Wattmo, Carina, et al.
Publicado: (2013)

Solitary living in Alzheimer’s disease over 3 years: association between cognitive and functional impairment and community-based services
por: Wattmo, Carina, et al.
Publicado: (2014)

Predictors of long-term cognitive outcome in Alzheimer's disease
por: Wattmo, Carina, et al.
Publicado: (2011)

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
por: Wattmo, Carina, et al.
Publicado: (2012)

A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2010)

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
por: Wattmo, Carina, et al.
Publicado: (2016)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
por: Palmqvist, Sebastian, et al.
Publicado: (2012)

Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden
por: Zahirovic, Iris, et al.
Publicado: (2018)

Survival among the older adults with clinical signs of Lewy body dementia in 40 Swedish nursing homes: a 6-year follow-up study
por: Zahirovic, Iris, et al.
Publicado: (2019)

Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies
por: Wattmo, Carina, et al.
Publicado: (2013)

Galantamine treatment in Alzheimer’s disease: response and long-term outcome in a routine clinical setting
por: Wallin, Åsa K, et al.
Publicado: (2011)

Reliability, validity and clinical correlates of the Quality of Life in Alzheimer’s disease (QoL-AD) scale in medical inpatients
por: Torisson, Gustav, et al.
Publicado: (2016)

Kynurenic Acid Levels in Cerebrospinal Fluid from Patients with Alzheimer’s Disease or Dementia with Lewy Bodies
por: Wennström, Malin, et al.
Publicado: (2014)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study
por: Torisson, Gustav, et al.
Publicado: (2013)

Cognitive impairment is undetected in medical inpatients: a study of mortality and recognition amongst healthcare professionals
por: Torisson, Gustav, et al.
Publicado: (2012)

Importance and added value of functional impairment to predict mortality: a cohort study in Swedish medical inpatients
por: Torisson, Gustav, et al.
Publicado: (2017)

Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
por: Buchhave, Peder, et al.
Publicado: (2009)

Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression
por: Wattmo, Carina, et al.
Publicado: (2017)

Why Do They Stay? Intention to Stay among Registered Nurses in Nursing Homes
por: Lee, Ji Yeon, et al.
Publicado: (2020)

Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients
por: Torisson, Gustav, et al.
Publicado: (2015)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
por: Mulugeta, Ezra, et al.
Publicado: (2011)

A Longitudinal Study of Physical Function in Patients with Early-Onset Dementia
por: Tangen, Gro Gujord, et al.
Publicado: (2012)

Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients
por: Wennström, Malin, et al.
Publicado: (2015)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Appropriateness of Acute Medical Admissions and Length of Stay
por: Smith, Helen E, et al.
Publicado: (1997)

Short-Stay Admissions Associated With Large COVID-19 Outbreaks in Maryland Nursing Homes
por: Mattingly, T. Joseph, et al.
Publicado: (2021)

Length of hospital stay prior to ICU admission and outcome
por: Simpson, K, et al.
Publicado: (2011)

Length of stay and reason for admission in an adolescents inpatient unit
por: Taracena Cuerda, M., et al.
Publicado: (2022)

OUTCOMES OF DISCONTINUING CHOLINESTERASE INHIBITORS IN NURSING HOME RESIDENTS WITH SEVERE DEMENTIA
por: Niznik, Joshua D, et al.
Publicado: (2019)

Correlation of admitted nursing home residents’ hospital length of stay and vitamin D levels
por: Mc Williams, Carla, et al.
Publicado: (2011)

Potentially inappropriate medications in relation to length of nursing home stay among older adults
por: Sönnerstam, Eva, et al.
Publicado: (2022)

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

Medications causing potential cognitive impairment are common in nursing home dementia units – A cross-sectional study
por: Kristensson, Jenny Hansen, et al.
Publicado: (2021)

A qualitative examination of inappropriate hospital admissions and lengths of stay
por: Hammond, Christina L, et al.
Publicado: (2009)

Predictive model of length of stay and discharge destination in neuroscience admissions
por: Stecker, M. M., et al.
Publicado: (2017)

Length of Stay of Psychiatric Admissions in a Tertiary Care Hospital
por: Basnet, Madhur, et al.
Publicado: (2018)

Length of stay in a home treatment team
por: Firdosi, Mudasir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bj6dhnmttqtj14nrpkhl960npm